# Vascular Augmentation of Late-life Unremitted Depression (VALUeD)

> **NCT01557153** · PHASE3 · UNKNOWN · sponsor: **Gateshead Health NHS Foundation Trust** · enrollment: 80 (estimated)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Amlodipine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01557153
- **Lead sponsor:** Gateshead Health NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2012-03-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01557153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01557153, "Vascular Augmentation of Late-life Unremitted Depression (VALUeD)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01557153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*